Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-09-27
1978-09-26
Torrence, Dolph H.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260308D, 260465D, 260465E, 424199, 424269, A61K 31275, C07C12178
Patent
active
041171586
ABSTRACT:
This disclosure describes novel 4-(monoalkylamino)benzonitriles and 5-[4-(monoalkylamino)phenyl]tetrazoles and homologs thereof useful as hypolipidemic and anti-atherosclerotic agents.
REFERENCES:
patent: 3868416 (1975-02-01), Albright et al.
American Cyanamid Company
Conroy, Jr. Edward A.
Torrence Dolph H.
LandOfFree
4-(Monoalkylamino)benzonitriles useful as anti-atherosclerotic a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(Monoalkylamino)benzonitriles useful as anti-atherosclerotic a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(Monoalkylamino)benzonitriles useful as anti-atherosclerotic a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2090509